Skip to content
Wize Pharma, Inc. episode artwork

Mar 5, 2018 4 min

Wize Pharma, Inc.

from OTCQB Podcast Hosted by OTC Markets Group

Wize Pharma (OTCQB: WIZPD) is a clinical-stage biopharmaceutical company currently focused on the treatment of ophthalmic disorders, including Dry Eye Syndrome. Wize Pharma has inlicensed certain rights to purchase, market, sell and distribute a formula known as LO2A, a drug developed for the treatment of Dry Eye Syndrome, and other ophthalmological illnesses, including Sjorgen's Syndrome and Conjunctivochalasis.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Wize Pharma, Inc.

0:00 4:50

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OTCQB Podcast?

This episode is 4 minutes long.

When was this OTCQB Podcast episode published?

This episode was published on March 5, 2018.

Can I download this OTCQB Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.